NCT07075809Completed
The Effectiveness of Laserpuncture on Chemotherapy-induced Leucopenia in Head and Neck Cancer Patients
The Effectiveness of Laserpuncture on Chemotherapy-induced Leucopenia and Quality of Life in Head and Neck Cancer Patients
Source: ClinicalTrials.gov · Last updated 5 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate if laserpuncture (laser acupuncture) can reduce leucopenia caused by chemotherapy and improve the quality of life in patients with head and neck cancer. The main questions it aims to answer are: * Does laserpuncture reduce the incidence of chemotherapy-induced Leucopenia ? * Does laserpuncture improve quality of life in these patients? Researchers will compare patients receiving laserpuncture therapy to a control group receiving sham laserpuncture to see if the intervention has a beneficial effect. Participants will: * Undergo six sessions of laserpunktur or sham laserpuncture during chemotherapy * Have leukocyte counts and absolute neutrophil counts measured before and 7-14 days after chemotherapy * Complete quality of life assessments using EORTC QLQ-C30 and EORTC QLQ-H\&N35 questionnaires
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 10 Jul 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 12 Dec 2025
- Lead sponsor
- Universitas Indonesia
- Diseases
- Head and neck cancer
- NCT number
- NCT07075809
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Oct 2025 to the primary completion date, 12 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with cancer lesions, ulcers, acute dermatitis, or exacerbation of chronic skin diseases at the selected acupuncture points.
- Patients with hemodynamic instability (patient vital signs outside the normal limits. Normal vital signs include axillary temperature of 36.5 - 37.5ºC, systolic blood pressure 102 - 131 mmHg, diastolic blood pressure 61 - 83 mmHg, pulse rate 60 - 100 beats/minute. Unstable if respiratory rate is above 25 breaths/minute or SpO2 \< 90%).
- Patients with a history of allergy to laser irradiation (skin hypersensitivity due to exposure to specific light).
- \- Patients with a history of uncontrolled seizures or epilepsy.
Other
- Patients with deformities or anatomical abnormalities of the ear.
- Patients with fever (body temperature \>38ºC).
Who the study is looking for
- Male or female patients with head and neck cancer, aged 18-60 years.
- Head and neck cancer patients diagnosed through histopathological examination, with cancer stages II to IV.
- Head and neck cancer patients undergoing chemotherapy with platinum-based chemotherapy drugs combined with 5-Fluorouracil, in the first treatment cycle.
- Leukocyte count greater than 5000/mm³.
- Patients who have signed informed consent and are willing to participate in the study until completion.
- Normal Mini-Mental State Examination (MMSE) score (27-31).
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitas Indonesia Coordinator of this site? Confirm its status | Jakarta Pusat | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.